Rationale for BRC-002, a High CBD Plant Extract, to reduce pain intensity in patients with Complex Regional Pain Syndrome (CRPS).
Complex Regional Pain Syndrome (CRPS) is a rare condition typically affecting one or more extremities following an injury or medical event (e.g., surgery, trauma). In addition to intense chronic pain and inflammation in the affected limb, patients with CRPS can suffer from co-morbidities such as depression, anxiety, and sleep disorders. There is currently no approved therapeutic for CRPS in the United States.
How our investigational therapy can potentially benefit patients
Certain cannabinoids have been shown to decrease inflammation and chronic pain. BRC-002, which is being developed to treat CRPS, received orphan designation from FDA in December 2024.
